Evrronal
Evrronal Brand names, Evrronal Analogs
- (+/-)-Secobarbital
- Barbosec
- Bipanal
- Bipinal sodium
- DEA No. 2315
- DEA No. 2316
- Evronal
- Evronal Sodium
- Evrronal
- Hypotrol
- Hyptran
- Imesonal
- Immenoctal
- Immenox
- Meballymal
- Meballymal sodium
- Meballymalum
- Novosecobarb
- Pramil
- Quinalbarbital
- Quinalbarbitone
- Quinalbarbitone sodium
- Quinalspan
- Sebar
- Seco 8
- Secobarbital (USP)
- Secobarbital Sodium
- Secobarbital [USAN:INN]
- Secobarbital suppository dosage form
- Secobarbitale [DCIT]
- Secobarbitalum [INN-Latin]
- Secobarbitone
- Seconal
- Seconal (TN)
- Seconal Sodium
- Sedutain
- Seotal
- Sodium Secobarbital
- Sodium Seconal
- Sodium quinalbarbitone
- Somosal
- Synate
- Trisomnin
Evrronal Brand Names Mixture
- No information avaliable
Evrronal Chemical_Formula
C12H18N2O3
Evrronal RX_link
No information avaliable
Evrronal fda sheet
Evrronal msds (material safety sheet)
Evrronal Synthesis Reference
No information avaliable
Evrronal Molecular Weight
238.283 g/mol
Evrronal Melting Point
100 oC
Evrronal H2O Solubility
550 mg/L
Evrronal State
Solid
Evrronal LogP
1.879
Evrronal Dosage Forms
Capsule
Evrronal Indication
For the Short-term treatment of intractable insomnia for patients habituated to barbiturates
Evrronal Pharmacology
Secobarbital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Evrronal Absorption
No information avaliable
Evrronal side effects and Toxicity
No information avaliable
Evrronal Patient Information
No information avaliable
Evrronal Organisms Affected
Humans and other mammals
